Tamoxifen: Five versus ten years - Is the end in sight?

被引：11
|
作者：
Abrams, JA [1 ]
机构：
[1] NCI, Canc Therapy Evaluat Program, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2001年 / 93卷 / 09期
关键词：
D O I：
10.1093/jnci/93.9.662
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：662 / 664
页数：3
相关论文
共 50 条
  • [21] About the Sanity of a Five-Ten Years' Murderer
    不详
    ALLGEMEINE ZEITSCHRIFT FUR PSYCHIATRIE UND PSYCHISCH-GERICHTLICHE MEDIZIN, 1937, 105 (7-8): : 259 - 268
  • [22] Cost-effectiveness of five versus ten years of alendronate treatment prior to drug holiday for women with osteoporosis
    Nayak, S.
    Greenspan, S. L.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (07) : 1273 - 1282
  • [23] 25 years on and no end in sight: a perspective on the role of RecG protein
    Lloyd, Robert G.
    Rudolph, Christian J.
    CURRENT GENETICS, 2016, 62 (04) : 827 - 840
  • [24] 20 Years of Mre11 Biology: No End in Sight
    Paull, Tanya T.
    MOLECULAR CELL, 2018, 71 (03) : 419 - 427
  • [25] Cost-effectiveness of five versus ten years of alendronate treatment prior to drug holiday for women with osteoporosis
    S. Nayak
    S. L. Greenspan
    Osteoporosis International, 2020, 31 : 1273 - 1282
  • [26] I Support School Integration, But...: Sheff v. O'Neill More than Ten Years Later and No End in Sight
    Sekou, Bilal
    EQUITY & EXCELLENCE IN EDUCATION, 2009, 42 (02) : 97 - 113
  • [27] 25 years on and no end in sight: a perspective on the role of RecG protein
    Robert G. Lloyd
    Christian J. Rudolph
    Current Genetics, 2016, 62 : 827 - 840
  • [28] Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors
    Panasci, LC
    Melnychuk, D
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (21) : 1631 - 1632
  • [29] Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors
    Fisher, B
    Dignam, J
    Bryant, J
    DeCillis, A
    Wickerham, DL
    Wolmark, N
    Costantino, J
    Redmond, C
    Fisher, ER
    Bowman, DM
    Deschenes, L
    Dimitrov, NV
    Margolese, RG
    Robidoux, A
    Shibata, H
    Terz, J
    Paterson, AHG
    Feldman, MI
    Farrar, W
    Evans, J
    Lickley, HL
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (21): : 1529 - 1542
  • [30] Ten years of the Genomics of Common Diseases: “The end of the beginning”
    Chris S. Haley
    Genome Biology, 17
12345